UNCOOKED ALERT: Indivior said to ...

Indivior, the FTSE 250-listed opiod addiction treatment company, is rumoured to be the mystery bidder circling Opiant Pharmaceuticals, the US-listed developer of medicines for drug addiction.

People following the situation have heard rumours Indivior has been talking to Opiant since December last year year about a possible offer for the company.

These people following the situation claimed Indivior is being advised by bankers at Centreview...